ORTHOFIX FEMORAL NAILING SYTEM

K973944 · Orthofix Srl · HSB · Dec 19, 1997 · Orthopedic

Device Facts

• Record ID: K973944
• Device Name: ORTHOFIX FEMORAL NAILING SYTEM
• Applicant: Orthofix Srl
• Product Code: HSB · Orthopedic
• Decision Date: Dec 19, 1997
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3020
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Orthofix Femoral Nailing System is indicated for the following: traumatic fractures; pathological fractures; refractures; non-unions; reconstructive surgery; and bone transport.

Device Story

Orthofix Femoral Nailing System consists of surgical grade stainless steel intramedullary nails, locking screws, and end caps; includes associated surgical instrumentation (reamers, drill bits, guides, impactors). Used by orthopedic surgeons in clinical/hospital settings for fracture fixation and bone reconstruction. Nails are inserted into the femoral canal; locking screws provide stability; end caps prevent tissue ingrowth. System facilitates bone healing and structural support for patients with femoral fractures or bone defects. Output is physical stabilization of the bone; clinical decision-making relies on surgeon assessment of fracture type and patient anatomy.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Materials: surgical grade stainless steel. Components: intramedullary nails (9-13mm diameters), locking screws (self-tapping), end caps. Instrumentation: drill bits, reamers, awls, trocars, guide wires, depth gauges, impactors/extractors. Mechanical fixation device; no energy source or software.

Indications for Use

Indicated for patients requiring stabilization of traumatic fractures, pathological fractures, refractures, non-unions, reconstructive surgery, and bone transport.

Regulatory Classification

Identification

An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.

Predicate Devices

• Tibial Nailing System (K961027)
• Howmedica Grosse & Kempf Locking Nail System (K860756)
• Smith & Nephew Richards Femoral Interlocking Nail System

Submission Summary (Full Text)

{0}------------------------------------------------

K97-39421

DEC 19 1997

## 510(k) SUMMARY1 Orthofix® Femoral Nailing System October 14, 1997

This summary is provided in accordance with the Safe Medical Devices Act of 1990 (SMDA). The information provided in the 510(k), premarket notification was in accordance with 21 CFR 807.87 and the SMDA.

#### Submitter of 510(k) 1.

Robert L. Sheridan (Consultant) Vice President, Device Evaluation C.L. McIntosh & Associates, Inc. 12300 Twinbrook Parkway, Suite 625 Rockville, MD 20852

Telephone: [phone] Facsimile: [phone]

#### 2. Name of Device:

- A. Trade/Proprietary Name:
Orthofix® Femoral Nailing System

- B. Common/Usual Name:
Femoral Nailing System

- C. Classification Name:
"Intramedullary Fixation Rod" (21 CFR 888.3020).

#### 3. Sponsor/Manufacturer:

ORTHOFIX Srl. Via delle Nazioni 9 37012 Bussolengo (VR), Italy

Any statement made in conjunction with this submission regarding a determination of substantial equivalence to any other product is intended only to refer to whether the product can be lawfully marketed without pre-market approval or reclassification and is not interpreted as an admission or any other type of evidence in patent infringement litigation. (Establishment Registration and Premarket Notification Procedures, Final Regulation, Preamble, August 23, 1977, FR 42520 (Docket No. 76N-0355)

{1}------------------------------------------------

Rolando Stanghellini, Director of Quality Assurance Attention:

011-39-45-6767030 Telephone: [phone] Facsimile:

#### Reason for Submitting the 510(k) 4.

We are submitting this document on behalf of our client, Orthofix Srl. (Orthofix), of Bussolengo, Italy. We are hereby notifying you of Orthofix's intention to commercially distribute its Femoral Nailing System for the first time in the U.S. Orthofix currently distributes a comparable nailing system for the tibia, Tibial Nailing System (K961027). Like our tibial nailing system and predicate devices our femoral nailing system includes a series of nails of varying diameters and lengths, locking screws and end caps, as well as the instruments and accessories used in their implantation and removal.

#### રું Device Description

The Orthofix femoral nail is manufactured from surgical grade stainless steel. The nail is available in five diameters, 9, 10, 11, 12 and 13 mm and varying lengths. The nails have two proximal and two distal locking holes. The screws are also manufactured from surgical grade stainless steel. They have a self tapping thread and are available in varying lengths. End caps are provided which screw into the nail's proximal end, preventing tissue ingrowth and allowing for easier explantation. The end caps are also manufactured from surgical grade stainless steel.

The system includes various instruments and accessories used during the implantation and removal of the nail and locking screws. They include drill bit kits, hand and flexible reamers, an awl, trocars, guide wires, a bone depth gauge, a slap hammer impactor/extractor, an X-ray overlay, a metal ruler, a screw extractor, sterilization boxes, guides, wrenches and other tools.

#### Intended Use 6.

The Orthofix Femoral Nailing System is indicated for the following: traumatic fractures; pathological fractures; refractures; non-unions; reconstructive surgery; and bone transport.

#### 7. Substantial Equivalence

The information provided in this submission demonstrates that the Orthofix Femoral Nailing System is substantially equivalent to legally marketed predicate femoral nailing systems. First, most of the components and instrumentation in this system are either identical to or comparable to those in our Tibial Nailing System (K961027). Secondly, these components and instrumentation are substantially equivalent to those provided in the predicate systems. Two such predicate devices are the Howmedica Grosse & Kempf

{2}------------------------------------------------

Locking Nail System (K860756) and Smith & Nephew Richards Femoral Interlocking Nail System. The Orthofix Femoral Nailing System and the legally marketed predicate devices are substantially equivalent in intended use, indicated use, material composition, size and shape.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or a stylized human figure, composed of flowing lines. The symbol is black, and the background is white.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DEC 19 1997

Mr. Robert L. Sheridan 'Vice President, Device Evaluation C.L. McIntosh & Associates, Inc. Representing Orthofix Srl 12300 Twinbrook Parkway, Suite 625 Rockville, Maryland 20852

Re: K973944 Orthofix® Femoral Nailing System Requlatory Class: II Product Code: HSB Dated: October 14, 1997 Received: October 16, 1997

Dear Mr. Sheridan:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Requlation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{4}------------------------------------------------

### Page 2 - Mr. Robert L. Sheridan

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

C. Colm M. Witten, Ph.D.

Cella M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

## Indications For Use

Device Name: Orthofix Femoral Nailing System

Indications For Use:

The Orthofix Femoral Nailing System is indicated for the following: traumatic fractures; pathological fractures; refractures; non-unions; reconstructive surgery; and bone transport.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use: (Per 21 CFR 801.109) OR

Over-The-Counter:

to coello

(Optional Format 1-2-96)

(Division Sign-Off)
Division of General Restorative Devices
510(k) Number K973944